Information on PDMR transactions in Dignitana AB

Dignitana AB announces PDMR transactions in the Company’s share with three purchases made by Dignitana leadership and board members on 22 and 23 August following publication of the Q2 Interim Report.

Dignitana CEO Fredrik Jonsson purchased 50,000 shares, Chairman of the Board of Directors Klas Arildsson purchased 50,000 shares, and Board member Fredrik Lindgren purchased 143,511 shares.

For More Information Contact 

Fredrik Jonsson, CEO, fredrik.jonsson@dignitana.com  +46 708766444

Klas Arildsson, Chairman of the Board of Directors, klas.arildsson@dignitana.com +46 709108003

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com. 

Tags: